Recently, several small studies have indicated that quetiapine may be useful in the treatment of drug-induced psychosis in patients with PD. However, there have been questions related to atypical antipsychotic therapy and patient selection and how that may affect response and tolerability, especiall
The effect of quetiapine in psychotic Parkinsonian patients with and without dementia
β Scribed by T. Prohorov; C. Klein; A. Miniovitz; E. Dobronevsky; J. M. Rabey
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 209 KB
- Volume
- 253
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A post hoc analysis of data from three placeboβcontrolled, doubleβblind, randomized trials was carried out to determine the efficacy of quetiapine in aggression and hostility in patients with schizophrenia. Quetiapine treatment induced statistically significantly greater improvements in
## Abstract This doubleβblind randomized study examined the effect of quetiapine (QTP) on drugβinduced psychosis (DIP) in Parkinson's disease (PD). Conventional antipsychotic drugs are associated with adverse extrapyramidal effects. QTP is a new atypical antipsychotic drug used in the treatment of
## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24βweek doub
originating from the peripheral rather than central retina. Correspondingly, VEP was also reported to be normal in MSA patients as it measures activity mainly originating from the central visual field. 7 Future studies will have to determine whether MSA patients show predominantly peripheral visual